Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Price Passes Below 200 Day Moving Average – Here’s What Happened
by Danessa Lincoln · The Markets DailyCipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $11.86 and traded as low as $11.77. Cipher Pharmaceuticals shares last traded at $11.80, with a volume of 4,582 shares trading hands.
Cipher Pharmaceuticals Stock Up 0.1%
The stock’s fifty day moving average price is $12.09 and its 200 day moving average price is $11.86.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops, acquires and commercializes prescription products in respiratory and dermatology markets. Founded in 2004 and headquartered in Vancouver, British Columbia, the company focuses on in-licensing established therapies and launching them under its own commercial infrastructure in North America.
In the respiratory segment, Cipher markets generic inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD).
See Also
- Five stocks we like better than Cipher Pharmaceuticals
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings